Pharminent

Pfizer plans to launch REMICADE biosimilar in US in November

Pfizer said it will begin shipping INFLECTRA (infliximab-dyyb)for injection, a biosimilar of REMICADE (infliximab) to wholesalers in the US in late November 2016. http://drugdelivery.pharmaceutical-business-review.com/news/pfizer-plans-to-launch-remicade-biosimilar-in-november-5034798

Filed under: Biosimilar